Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae - Wikidata - wikimedia - TriplyDB

Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae

Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae

http://www.wikidata.org/entity/Q28208256

about

Q28175502 Q29031776

sameAs

Pneumococcal vaccine and patients with pulmonary diseases The role of vaccination in preventing pneumococcal disease in adults Severe necrotizing pneumonia in a child with pandemic (H1N1) influenza.Empyema associated with community-acquired pneumonia: a Pediatric Investigator's Collaborative Network on Infections in Canada (PICNIC) study.Costs of treating children with complicated pneumonia: a comparison of primary video-assisted thoracoscopic surgery and chest tube placement.Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah.Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers.Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology.Direct Streptococcus pneumoniae real-time PCR serotyping from pediatric parapneumonic effusions.National hospitalization trends for pediatric pneumonia and associated complications Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin.Microbiological diagnosis of empyema in children: comparative evaluations by culture, polymerase chain reaction, and pneumococcal antigen detection in pleural fluids.Gender differentials in the impact of parental death: Adolescent's sexual behaviour and risk of HIV infection in rural South Africa.Pneumococcal serotypes causing pneumonia with pleural effusion in pediatric patients.Clonality of Streptococcus pneumoniae serotype 1 isolates from pediatric patients in the United States.Validation of the English version of the UNESP-Botucatu multidimensional composite pain scale for assessing postoperative pain in cats Paediatric community-acquired pneumonia: current concept in pharmacological control.Nutritional status of children hospitalized for parapneumonic effusion Clinical features, aetiology and outcome of empyema in children in the north east of England.Value of Lung Ultrasonography in the Diagnosis and Outcome Prediction of Pediatric Community-Acquired Pneumonia with Necrotizing Change.Towards New Broader Spectrum Pneumococcal Vaccines: The Future of Pneumococcal Disease Prevention.Overcoming current obstacles in the management of bacterial community-acquired pneumonia in ambulatory children.Immunomodulatory activity of pidotimod administered with standard antibiotic therapy in children hospitalized for community-acquired pneumonia.The Clinical Characteristics and Predictors of Refractory Mycoplasma pneumoniae Pneumonia in Children Aging and bone health in individuals with developmental disabilities.Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines.Streptococcus pneumoniae-associated pneumonia complicated by purulent pericarditis: case series Problem-based learning: a review of current issues relevant to physiotherapy education.Early menarcheal age and risk for later depressive symptomatology: the role of childhood depressive symptoms.Emergence of parapneumonic empyema in the USA.Effective treatment strategies for paediatric community-acquired pneumonia.Pneumococcal necrotizing pneumonia in Utah: does serotype matter?Potential impact of accelerating the primary dose of pneumococcal conjugate vaccine in infants.Distribution of Streptococcus pneumoniae serotypes that cause parapneumonic empyema in Turkey.Pediatric parapneumonic empyema, Spain.Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates.Necrotizing pneumonia complicated by early and late pneumatoceles.Parapneumonic empyema in children before the era of pneumococcal vaccination.Pharmacotherapy for pneumococcal infections: an update.

P2860

Q26825944-305B02D0-773E-4D3F-A051-9F85E8CA20E7 Q26825944-66F19366-C0DE-4B6D-8429-D819B9EED177 Q28396749-09EA6622-9D77-4DCB-BAFC-50852E4CB72D Q28396749-CB75AE70-BB4A-4CB7-BC36-0BB5152F6FF8 Q30397044-C61FA64A-91D0-4024-8414-2F3E87661029 Q33371823-FD9D1027-4CC5-47CB-BB04-34E338566B52 Q33556037-0D25C715-FFE2-49B9-BD41-382F79618064 Q33627308-760057D9-9F27-45CC-B3AB-18C3CF87D25D Q33909172-5828A438-0540-4E37-99E0-484C843BB7AB Q33947633-83FF1199-E4B9-41C7-8BB9-96C6E59ACAC4 Q33985797-E74E19FF-20FC-4758-ACCD-0DB0E2EA26B4 Q34039927-D5774012-66E5-4B95-BD6C-1FC2ED2FA8A4 Q34099491-09C3532B-884B-41FA-B41C-A69640BF7991 Q34315525-82A7F3C0-2B99-4058-8D40-5E8CF5F8B0DC Q34507308-41F498F7-AE15-4504-A837-12C3C926EA5A Q34509813-B18C03C8-21A0-4C8A-BEA8-A7DACC85FA8F Q34596528-EAB2131A-63E4-4564-802A-4F6B3858BE66 Q34779899-8EADB16B-2D03-4474-9E80-B21A486509C2 Q34835756-5F30D227-8305-4656-AE00-2F1969BA1DC9 Q35124715-B621B26F-B395-432C-B892-C963770A9945 Q35140253-FAB4FA66-D26B-4802-AE95-79C903A78F74 Q35536725-430DC331-BE32-4F62-892E-650237FE4D2C Q35667200-15F30FF0-7CED-4F86-8098-2361396DDA02 Q35826592-0D6F5B80-5DCC-4424-AFA8-12EDBE04B6BB Q36022938-E9DEC978-C66F-41EB-ABC7-E2457EA6F0FB Q36023838-C87B31F9-B789-4387-8BEF-783CEEF0BBE0 Q36030140-A2767887-394A-4E48-9D75-13500CDBED45 Q36128793-D3D0D47D-C5DB-478E-AE05-2195CE8D8B61 Q36156085-646EB8B2-47E0-443C-970A-0F71DB6CB9E8 Q36256618-BAF39754-3031-4BC1-9D3F-3AACF659D013 Q36356956-BCA70121-78D8-4C4C-B149-6226ECB0E252 Q36448897-109E2882-6AFD-483D-BD33-9F5D39982952 Q36763044-738ACB77-0CAD-45E3-9518-DE7595802E78 Q36828136-D447C6F9-3675-463B-82F5-78F7AABCD5AE Q36905065-A53C02B3-99E7-42E6-B13E-672C854C6C81 Q36907321-8200EB00-C55D-46C2-A0EF-AA340D8D9D6D Q36970232-0B2E39FC-3C13-4060-BAB0-E1AD8EC4A5A9 Q37015614-F8D4FDC2-DADE-4931-BD29-646C08EF1799 Q37058924-6EBD1D4C-D5A5-4946-AD99-00921D1BB324 Q37181716-2787B13C-68BF-41FE-8174-042EBA36FED2

P2860

Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae

http://www.wikidata.org/entity/Q28208256

description

2002 nî lūn-bûn

@nan

2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Clinical characteristics of ch ...... ed by Streptococcus pneumoniae

@ast

Clinical characteristics of ch ...... ed by Streptococcus pneumoniae

@en

Clinical characteristics of ch ...... ed by Streptococcus pneumoniae

@nl

type

label

Clinical characteristics of ch ...... ed by Streptococcus pneumoniae

@ast

Clinical characteristics of ch ...... ed by Streptococcus pneumoniae

@en

Clinical characteristics of ch ...... ed by Streptococcus pneumoniae

@nl

altLabel

Clinical Characteristics of Ch ...... ed by Streptococcus pneumoniae

@ast

Clinical Characteristics of Ch ...... ed by Streptococcus pneumoniae

@en

prefLabel

Clinical characteristics of ch ...... ed by Streptococcus pneumoniae

@ast

Clinical characteristics of ch ...... ed by Streptococcus pneumoniae

@en

Clinical characteristics of ch ...... ed by Streptococcus pneumoniae

@nl

P1433

Q28208256-1F5381AE-3436-4B10-A5A7-1FE08CA617D1

P1476

Q28208256-73BBBB2D-E729-43B6-A3C5-B4AD31EA8F0E

Q28208256-E353CA89-D13A-43A2-B7FB-8B22BAD716AE

P2093

Q28208256-060CD5E9-0FEF-4DBB-8120-CBAF5301A528

Q28208256-1FA481F4-7514-42AF-AEF9-16B6C72FA3C6

Q28208256-211DBBD5-8D88-4A56-99DD-138DA323C1E0

Q28208256-37343C38-A6AF-439D-8C18-67AF4E602D96

Q28208256-46522423-125D-41E3-9CCA-63FB9F4C3D32

Q28208256-46FF3F00-F92B-40EF-B09C-0BE63E3AAEDC

Q28208256-50F2BB9E-60C3-4DD7-A2B9-DDC244693502

Q28208256-72A0500E-5367-49D0-8943-81DB736757B7

Q28208256-7CA6B7FC-B931-4496-A2D3-A2B8528537EA

Q28208256-8518E67A-5F7B-4AF4-BF5D-7050CF795B43

P304

Q28208256-11E39F8E-6FF9-425B-97E5-446651F78D21

P31

Q28208256-97638132-9E01-4A2D-BC25-57379917FF1B

P3181

Q28208256-32DF9F93-4B43-4199-8D1E-487216B0D51F

P356

Q28208256-70A58101-5A2E-4AD6-8D52-49FD6209713E

P407

Q28208256-1168895E-5F55-4DCF-8A3C-9F34B4597FE7

P433

Q28208256-867005BF-418C-4ED5-AB29-3866478BFBBD

Q28208256-89B1C1E0-064A-4E60-9506-055AFC749950

P478

Q28208256-2354CEAE-36FB-4BDD-B045-2ACA665BE8FB

P577

Q28208256-1443A2CE-509D-4FB5-B634-720023E29F71

Q28208256-8BFF6DC1-5C08-4344-932B-8BAA763EE4A2

P5875

Q28208256-8A358D87-8CEE-4A39-BD13-3821D4AA3BAC

P698

Q28208256-513E2893-B77C-4384-857C-DCC6DFED5B6F

P921

Q28208256-441CA8C2-885B-4A19-A4EA-7991DEBFD370

P3181

P356

P1433

P1476

Clinical Characteristics of Ch ...... ed by Streptococcus pneumoniae

@en

Clinical characteristics of ch ...... ed by Streptococcus pneumoniae

@en

P2093

E. O. Mason

http://www.w3.org/2001/XMLSchema#string

E. R. Wald

http://www.w3.org/2001/XMLSchema#string

Edward O Mason

http://www.w3.org/2001/XMLSchema#string

Ellen R Wald

http://www.w3.org/2001/XMLSchema#string

G. E. Schutze

http://www.w3.org/2001/XMLSchema#string

Gordon E Schutze

http://www.w3.org/2001/XMLSchema#string

J. S. Bradley

http://www.w3.org/2001/XMLSchema#string

John S Bradley

http://www.w3.org/2001/XMLSchema#string

K. S. Kim

http://www.w3.org/2001/XMLSchema#string

Kwang Sik Kim

http://www.w3.org/2001/XMLSchema#string

P304

1-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1248310

http://www.w3.org/2001/XMLSchema#string

P356

10.1542/PEDS.110.1.1

http://www.w3.org/2001/XMLSchema#string

P407

P433

1 Pt 1

http://www.w3.org/2001/XMLSchema#string

1

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11281748

http://www.w3.org/2001/XMLSchema#string

P698

12093940

http://www.w3.org/2001/XMLSchema#string

P921